5HT2C receptor modulator compositions and methods of use
US8546378B2 · kind B2 · utility
0Cited by
46References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 12, 2012 |
| Grant date | Oct 1, 2013 |
| Priority date | — |
| Expiry date | Mar 12, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist. In addition, the invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist having Formula (I): or a pharmaceutically acceptable salt, solvate or hydrate thereof. These compositions are useful in pharmaceutical compositions whose use includes the treatment of obesity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.